Format

Send to

Choose Destination
Biol Blood Marrow Transplant. 2014 Mar;20(3):421-4. doi: 10.1016/j.bbmt.2013.11.032. Epub 2013 Dec 7.

Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

Author information

1
Division of Hematology, Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: msabloff@ottawahospital.on.ca.
2
Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic Foundation, Cleveland, Ohio.
3
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
4
Center for International Blood & Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
5
Division of Hematologic Malignancies and Stem Cell Transplantation, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio.
6
Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts.
7
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
8
Division of Oncology and Hematology, The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.
9
Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
10
Hematopoietic Cell Transplantation Program, University Hospitals Case Medical Center, University of Virginia Health System, Charlottesville, Virginia.
11
Division of Hematology and Oncology, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, Texas.
12
Division of Hematology and Oncology, Department of Medicine, Shands Healthcare & University of Florida, Gainesville, Florida.
13
Division of Hematology and Oncology, Stony Brook University Medical Center, Stony Brook, New York.
14
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
15
Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
16
Division of Hematology, Oncology and Transplant, University of Minnesota Medical Center, Fairview, Minneapolis, Minneapolis.
17
Department of Leukemia, MD Anderson Cancer Center, Houston, Texas.
18
Center for Hematologic Malignancies, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
19
Section of Hematology, Division of Experimental Medicine, Department of Medicine, Imperial College, London, United Kingdom.

Abstract

An allogeneic hematopoietic cell transplantation from an HLA-identical donor after high-dose (myeloablative) pretransplantation conditioning is an effective therapy for some people with chronic lymphocytic leukemia (CLL). Because CLL is a highly radiosensitive cancer, we hypothesized that total body irradiation (TBI) conditioning regimens may be associated with better outcomes than those without TBI. To answer this, we analyzed data from 180 subjects with CLL receiving myeloablative doses of TBI (n = 126) or not (n = 54), who received transplants from an HLA-identical sibling donor between 1995 and 2007 and reported to the Center for International Blood & Marrow Transplant Research. At 5 years, treatment-related mortality was 48% (95% confidence interval [CI], 39% to 57%) versus 50% (95% CI, 36% to 64%); P = NS. Relapse rates were 17% (95% CI, 11% to 25%) versus 22% (95% CI, 11% to 35%); P = NS. Five-year progression-free survival and overall survival were 34% (95% CI, 26% to 43%) versus 28% (95% CI, 15% to 42%); P = NS and 42% (95% CI, 33% to 51%) versus 33% (95% CI, 19% to 48%); P = NS, respectively. The single most common cause of death in both cohorts was recurrent/progressive CLL. No variable tested in the multivariate analysis was found to significantly affect these outcomes, including having failed fludarabine. Within the limitations of this study, we found no difference in HLA-identical sibling transplantation outcomes between myeloablative TBI and chemotherapy pretransplantation conditioning in persons with CLL.

KEYWORDS:

Chronic lymphocytic leukemia; Conditioning; Myeloablative; Total body irradiation

PMID:
24321745
PMCID:
PMC4026353
DOI:
10.1016/j.bbmt.2013.11.032
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center